Live from the NIH registry
Studies recruiting near New Orleans right now
Top 25 of 556 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: National Cancer Institute (NCI)
Impact of Biosynthetic Mesh on Paraesophageal Hernia Repair
Hiatal Hernia
N/A
Interventional 200 participants sought
Louisiana State University School of Medicine — New Orleans, Louisiana (11.8 mi)
· Sponsor: Weill Medical College of Cornell University
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Tulane University — New Orleans, Louisiana (11.8 mi)
· Sponsor: Westat
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Ochsner Clinic Foundation ( Site 0189) — New Orleans, Louisiana (11.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — New Orleans, Louisiana (11.8 mi)
· Sponsor: Sameek Roychowdhury
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Louisiana State University Health Science Center — New Orleans, Louisiana (11.8 mi)
· Sponsor: SWOG Cancer Research Network
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Louisiana State University Health Science Center — New Orleans, Louisiana (11.8 mi)
· Sponsor: NRG Oncology
Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
Systemic Lupus Erythematosus of Childhood (Disorder)
N/A
Interventional 175 participants sought
Children's Hospital of New Orleans/ Tulane University — New Orleans, Louisiana (11.8 mi)
· Sponsor: Michigan State University
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Phase 2
Interventional 200 participants sought
UMC New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: Novartis Pharmaceuticals
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Tulane University — New Orleans, Louisiana (11.8 mi)
· Sponsor: Jaeb Center for Health Research
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
Ochsner Health — Jefferson, Louisiana (15.2 mi)
· Sponsor: Astellas Pharma Inc
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
Ochsner Clinic Foundation — New Orleans, Louisiana (11.8 mi)
· Sponsor: Eli Lilly and Company
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Tulane University School of Medicine — New Orleans, Louisiana (11.8 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: National Cancer Institute (NCI)
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
University Medical Center New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: NRG Oncology
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
University Medical Center New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: NRG Oncology
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
DelRicht Research - LCMC Health Urgent Care - Lakeview — New Orleans, Louisiana (11.8 mi)
· Sponsor: Crystalys Therapeutics
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
GI Alliance - Gastro Group and Endocenter - Mandeville — Mandeville, Louisiana (21.6 mi)
· Sponsor: Eli Lilly and Company
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction
Phase 3
Interventional 2,000 participants sought
Ochsner Medical Center — New Orleans, Louisiana (11.8 mi)
· Sponsor: Uppsala University
Randomized Clinical Trial of Re-Evaluating Suicidal Thoughts in Veterans
Suicidal Ideation, Suicide, Attempted
N/A
Interventional 180 participants sought
Southeast Louisiana Veterans Health Care System, New Orleans, LA — New Orleans, Louisiana (11.8 mi)
· Sponsor: VA Office of Research and Development
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Children's Hospital New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: National Cancer Institute (NCI)
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Omega Clinical Research — Metairie, Louisiana (14.6 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 140 participants sought
University Medical Center New Orleans /ID# 274755 — New Orleans, Louisiana (11.8 mi)
· Sponsor: AbbVie
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Women's Cancer Care ( Site 0088) — Covington, Louisiana (29.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
Papillomavirus Vaccines, Human Immunodeficiency Virus
Phase 4
Interventional 250 participants sought
University Medical Center New Orleans — New Orleans, Louisiana (11.8 mi)
· Sponsor: Louisiana State University Health Sciences Center in New Orleans